Cyclin T1 antibodies are primarily used to investigate P-TEFb complex dynamics, Tat-mediated HIV-1 transcription, and post-translational modifications affecting protein stability. Key commercially available antibodies include:
| Antibody Name | Clone/Product Code | Host Species | Applications | Species Reactivity |
|---|---|---|---|---|
| Proteintech 20992-1-AP | Polyclonal | Rabbit | WB, IHC, IF | Human, Mouse, Rat |
| Cell Signaling #81464 | D1B6G | Rabbit | WB, IP, ChIP, CUT&RUN, CUT&Tag | Human, Mouse, Rat, Monkey |
| Abcam ab264325 | Polyclonal | Rabbit | WB, IP, IHC-P | Human |
Proteintech 20992-1-AP: Validated for detecting endogenous CycT1 (~81 kDa) in human cell lines (e.g., HeLa, HEK-293T) .
Cell Signaling #81464: Detects CycT1 at 1:1000 dilution, optimized for high sensitivity in nuclear extracts .
Cell Signaling #81464: Validated in ChIP assays to study CycT1 interactions with HIV-1 promoters and host chromatin .
Abcam ab264325: Successfully immunoprecipitates CycT1 from HeLa lysates, confirming interactions with CDK9 and Tat .
CycT1 is essential for Tat-mediated HIV-1 transcriptional activation. Antibodies like #81464 have demonstrated that human CycT1, but not rodent variants, supports Tat-TAR RNA binding and P-TEFb recruitment .
Mutant CycT1 proteins (e.g., CycT1L203P) show reduced stability and fail to bind CDK9, as shown via cycloheximide pulse-chase experiments using Proteintech 20992-1-AP .
Phosphorylation at specific threonine residues (e.g., Thr-286) stabilizes CycT1-CDK9 interactions. PKC inhibitors reduce CycT1 levels in activated CD4+ T cells, as quantified using Abcam ab264325 .
Proteasomal degradation of unbound CycT1 is reversed by inhibitors like bortezomib, confirmed via WB with Cell Signaling #81464 .
Cycloheximide Treatment: Wild-type CycT1 remains stable (>24 hr half-life), while mutants (CycT1T3A) degrade rapidly (~6 hr) .
Bortezomib Rescue: Restores mutant CycT1 expression levels by blocking proteasomal degradation .
| Condition | Effect on CycT1-CDK9 Interaction | Antibody Used |
|---|---|---|
| PKC Inhibition | Reduced binding (up to 20-fold) | Abcam ab264325 |
| Coexpression with PKCαK386R | ~9.1-fold reduction in CycT1 levels | Cell Signaling #81464 |
CycT1 antibodies have identified PKC isoforms as regulators of P-TEFb assembly, suggesting PKC inhibitors could disrupt HIV-1 latency .
Dominant-negative CycT1 mutants (e.g., CycT1-U7) degrade Tat and inhibit viral transcription, offering potential gene therapy strategies .
CYCT1-1 antibody is an immunological reagent designed to detect and bind to cyclin T1, specifically the CYCT1-1 protein in plant samples. The target antigen is encoded by the CYCT1-1 gene, which is a plant homolog of the mammalian CCNT1 gene. In humans, cyclin T1 is a nuclear protein with 726 amino acid residues and a molecular weight of approximately 80.7 kilodaltons, with two identified isoforms . In plants, CYCT1-1 functions as part of the transcriptional machinery, though with structural and functional differences from its mammalian counterpart. The antibody enables researchers to study the expression, localization, and interactions of CYCT1-1 in various plant tissues and experimental conditions .
CYCT1-1 antibody is primarily used for Western Blot (WB) and Enzyme-Linked Immunosorbent Assay (ELISA) applications in plant research . These applications allow researchers to:
Quantify CYCT1-1 protein expression levels in different plant tissues, developmental stages, or treatment conditions
Assess protein localization in cellular fractions
Evaluate protein-protein interactions through co-immunoprecipitation experiments
Monitor changes in CYCT1-1 expression during different physiological or stress conditions
Validate genetic manipulation outcomes in transgenic plants
The antibody specifically recognizes plant CYCT1-1 proteins, making it suitable for studies in Arabidopsis and other plant species but not for animal or human samples .
For optimal performance and longevity of CYCT1-1 antibody:
Store the antibody at -20°C for long-term storage
Avoid repeated freeze-thaw cycles by preparing small aliquots upon receipt
When working with the antibody, keep it on ice or at 4°C
Dilute only the amount needed for immediate use in appropriate buffer
Monitor storage conditions regularly to ensure temperature stability
Check expiration dates and antibody clarity before use (cloudiness or precipitation may indicate deterioration)
For reconstituted lyophilized antibodies, follow manufacturer's recommendations for buffer composition
Proper storage and handling are essential for maintaining antibody specificity and sensitivity in experimental applications.
For successful Western blotting with CYCT1-1 antibody in plant samples:
Sample Preparation:
Extract total protein from plant tissue using a plant-specific extraction buffer containing protease inhibitors
Determine protein concentration using Bradford or BCA assay
Prepare samples in Laemmli buffer with reducing agent and heat at 95°C for 5 minutes
Gel Electrophoresis and Transfer:
Load 20-50 μg of protein per lane on a 10-12% SDS-PAGE gel
Use prestained molecular weight markers to track migration
Transfer to PVDF membrane (preferred over nitrocellulose for plant proteins)
Verify transfer efficiency with reversible staining (Ponceau S)
Antibody Incubation:
Block membrane with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature
Incubate with CYCT1-1 antibody at 1:1000 dilution in blocking buffer overnight at 4°C
Wash 4 times with TBST, 5 minutes each
Incubate with secondary antibody (anti-mouse HRP) at 1:5000 dilution for 1 hour at room temperature
Wash 4 times with TBST, 5 minutes each
Detection:
Apply chemiluminescent substrate and capture signal using imaging system
Expected molecular weight for Arabidopsis CYCT1-1 is approximately 55-60 kDa
Validate specificity using positive and negative controls
This protocol may require optimization based on specific plant species and tissue types being analyzed .
When encountering weak or non-specific signals with CYCT1-1 antibody, consider the following troubleshooting approaches:
For Weak Signals:
Increase antibody concentration (try 1:500 instead of 1:1000)
Extend primary antibody incubation time to 24-48 hours at 4°C
Increase protein loading (up to 100 μg per lane)
Use enhanced sensitivity chemiluminescent substrates
Optimize extraction buffer to ensure efficient protein extraction from plant tissues
Consider using a detection system with signal amplification
For Non-specific Signals:
Increase blocking stringency (5-10% blocking agent)
Add 0.1-0.5% Tween-20 to antibody dilution buffer
Pre-absorb antibody with plant extract from negative control tissue
Increase washing duration and number of washes
Decrease secondary antibody concentration
Use gradient gels to better separate proteins of similar molecular weights
Consider using a monoclonal alternative if available
General Optimization:
Test different membrane types (PVDF vs. nitrocellulose)
Optimize transfer conditions for high molecular weight proteins
Include appropriate positive and negative controls in each experiment
Verify protein integrity during extraction using Coomassie-stained gels
Methodical troubleshooting and careful documentation of conditions will help identify the optimal parameters for specific experimental systems.
Rigorous experimental design requires appropriate controls when using CYCT1-1 antibody:
Essential Controls:
Positive Control: Include protein extract from plants with known CYCT1-1 expression (e.g., Arabidopsis seedlings)
Negative Control: Use one of the following:
Extract from cyct1-1 knockout/knockdown plants
Pre-immune serum in place of primary antibody
Secondary antibody only (omitting primary antibody)
Loading Control: Probe the same membrane with antibodies against constitutively expressed proteins:
Actin (plant-specific anti-actin antibody)
GAPDH
Tubulin
Peptide Competition: Pre-incubate antibody with excess CYCT1-1 peptide to confirm specificity
Cross-Reactivity Control: Test antibody on protein extracts from non-target plant species
Technical Controls:
| Control Type | Purpose | Implementation |
|---|---|---|
| Dilution Series | Determine optimal antibody concentration | Test primary antibody at 1:500, 1:1000, 1:2000, 1:5000 dilutions |
| Time Course | Determine optimal exposure times | Capture multiple exposures (30 sec, 1 min, 5 min, 15 min) |
| Extraction Method | Ensure complete protein extraction | Compare different lysis buffers and extraction protocols |
| Loading Gradient | Validate linear detection range | Load 10, 20, 40, 80 μg of total protein |
Including these controls helps validate results and troubleshoot experimental issues, ensuring reliable and reproducible findings .
CYCT1-1 antibody can be employed in sophisticated experimental designs to elucidate the role of cyclin T1 in plant-pathogen interactions:
Infection Time Course Analysis:
Infect plants with pathogens (viral, bacterial, or fungal)
Collect samples at various timepoints post-infection
Perform Western blot analysis with CYCT1-1 antibody to track changes in expression levels
Correlate CYCT1-1 expression with disease progression or resistance
Subcellular Fractionation:
Separate infected plant tissues into nuclear, cytoplasmic, and membrane fractions
Analyze CYCT1-1 localization in each fraction using the antibody
Determine if pathogen infection alters CYCT1-1 cellular distribution
Co-Immunoprecipitation (Co-IP):
Prepare lysates from infected and control plants
Use CYCT1-1 antibody for immunoprecipitation
Analyze co-precipitating proteins by mass spectrometry
Identify pathogen effectors or plant defense proteins that interact with CYCT1-1
Chromatin Immunoprecipitation (ChIP):
Perform ChIP with CYCT1-1 antibody on infected vs. control plants
Sequence precipitated DNA (ChIP-seq) to identify genomic regions bound by CYCT1-1
Analyze if pathogen infection alters CYCT1-1 recruitment to defense-related genes
This multifaceted approach can reveal whether plant pathogens target or manipulate CYCT1-1 function during infection, potentially uncovering new mechanisms of plant immunity or pathogen virulence strategies.
While CYCT1-1 antibody specifically targets plant cyclin T1, comparative studies between plant and human cyclin T1 can provide valuable insights into HIV-1 Tat interactions:
Structural Comparison Studies:
Use CYCT1-1 antibody to purify plant cyclin T1
Compare structural features with human cyclin T1 using X-ray crystallography or cryo-EM
Identify conserved and divergent regions that might explain species-specific interactions with Tat
Functional Domain Analysis:
Research has shown that human cyclin T1 contains a Tat-recognition motif (TRM) that is critical for HIV-1 Tat binding and transcriptional activation . Comparative studies can:
Evaluate if plant CYCT1-1 contains similar structural elements
Test chimeric constructs combining plant and human cyclin T1 domains
Use CYCT1-1 antibody to verify expression and localization of these constructs
Therapeutic Development Insights:
Studies have identified compounds that inhibit HIV-1 replication by targeting the cyclin T1-Tat interaction . The study of plant CYCT1-1 may:
Provide evolutionary context for structure-function relationships
Identify naturally evolved resistance mechanisms in plant cyclins
Inform design of more specific inhibitors targeting human cyclin T1
The molecular dynamics simulation studies of cyclin T1-Tat interactions have revealed that the dynamic structural change of cyclin T1 H2' helix is indispensable for its activity in Tat function . Understanding the structural parallels in plant CYCT1-1 could provide evolutionary insights into this important protein family.
Post-translational modifications, particularly phosphorylation, can significantly impact CYCT1-1 function and detection:
Impact on Antibody Detection:
Phosphorylation may alter epitope accessibility or antibody binding affinity
Some antibody preparations may preferentially recognize phosphorylated or non-phosphorylated forms
To comprehensively detect all forms of CYCT1-1:
Use multiple antibodies targeting different epitopes
Compare results from native and denaturing conditions
Consider using phosphorylation-state specific antibodies if available
Functional Analysis of Phosphorylation:
Treat protein extracts with phosphatases before immunoblotting
Compare migration patterns of treated vs. untreated samples
Use Phos-tag™ SDS-PAGE to separate phosphorylated from non-phosphorylated forms
Perform 2D gel electrophoresis to resolve different phosphorylated species
Experimental Approach to Study Phosphorylation:
| Treatment | Purpose | Expected Outcome | Detection Method |
|---|---|---|---|
| Lambda phosphatase | Remove phosphorylation | Band shift to lower MW | Western blot with CYCT1-1 antibody |
| Kinase inhibitors | Block specific kinase pathways | Altered phosphorylation pattern | Western blot + phospho-specific staining |
| Stress conditions | Induce phosphorylation changes | Modified activity or localization | Immunofluorescence or fractionation |
| Site-directed mutagenesis | Validate phosphorylation sites | Functional changes in mutants | Complementation assays |
In human cells, the phosphorylation of cyclin T1 affects its interaction with Tat and RNA polymerase II, which is crucial for HIV-1 transcription . Similar regulatory mechanisms may exist in plant CYCT1-1, though with different functional outcomes due to the absence of viral transcription factors like Tat in plants.
While studying plant CYCT1-1 with specific antibodies, researchers can gain comparative insights relevant to human HIV-1 pathogenesis:
Evolutionary Conservation Analysis:
Use CYCT1-1 antibody to identify and purify plant cyclin T1
Perform sequence and structural comparisons with human cyclin T1
Identify functionally conserved domains that may be essential for transcriptional regulation
Map species-specific differences that explain why plant cyclins cannot support HIV-1 transcription
Functional Domain Studies:
Molecular dynamics simulation and experimental verification have shown that the dynamic structural change of human cyclin T1 H2' helix is indispensable for its activity in Tat function . Comparative studies can:
Analyze if plant CYCT1-1 contains similar structural elements
Study the flexibility of corresponding regions in plant cyclin T1
Identify naturally evolved structural variations that prevent Tat binding
Alternative Models for Therapeutic Development:
Express human-plant chimeric cyclin T1 proteins in plant systems
Use CYCT1-1 antibody to confirm expression and proper folding
Test candidate HIV-1 transcription inhibitors against these constructs
Leverage plant systems as preliminary screening platforms for drug discovery
This cross-kingdom comparative approach can identify fundamental principles of cyclin T1 function that might be leveraged for therapeutic development against HIV-1 .
To investigate interactions between CYCT1-1 and plant-specific transcription factors, researchers can employ several sophisticated approaches:
Co-Immunoprecipitation (Co-IP) and Pull-Down Assays:
Use CYCT1-1 antibody for immunoprecipitation from plant extracts
Identify co-precipitating proteins by mass spectrometry
Validate interactions with candidate transcription factors using reciprocal Co-IP
For transient interactions, consider using crosslinking before extraction
Bimolecular Fluorescence Complementation (BiFC):
Generate fusion constructs of CYCT1-1 and candidate transcription factors with split fluorescent protein fragments
Express in plant protoplasts or through transient transformation
Analyze reconstituted fluorescence using confocal microscopy
Include appropriate controls to verify specificity of interactions
Yeast Two-Hybrid (Y2H) and Split-Ubiquitin Systems:
Create bait constructs with CYCT1-1 and prey constructs with candidate transcription factors
Screen for interactions in yeast systems
Validate positive interactions using deletion constructs to map interaction domains
Confirm with in planta methods like Co-IP using CYCT1-1 antibody
Chromatin Immunoprecipitation followed by Sequencing (ChIP-seq):
Perform ChIP with CYCT1-1 antibody
Sequence precipitated DNA to identify genomic binding regions
Compare with binding sites of candidate transcription factors
Identify co-occupied regions suggesting functional interactions
These methodologies can reveal plant-specific transcription networks involving CYCT1-1, which may differ significantly from the well-characterized interactions of human cyclin T1 with transcription factors and the HIV-1 Tat protein .
When evaluating different CYCT1-1 antibody preparations for research applications, consider these comparative parameters:
Comparison of Antibody Types:
| Antibody Type | Advantages | Limitations | Best Applications |
|---|---|---|---|
| Polyclonal CYCT1-1 | Higher sensitivity; Recognizes multiple epitopes | Batch-to-batch variation; Potential cross-reactivity | Western blot; ELISA |
| Monoclonal CYCT1-1 | Consistent performance; High specificity | May be sensitive to epitope modifications; Lower sensitivity | Immunoprecipitation; ChIP |
| Recombinant CYCT1-1 | Defined specificity; Renewable source | May have limited epitope recognition | Specialized applications |
Performance Evaluation Methods:
Side-by-side Western blot comparison using the same samples and conditions
Epitope mapping to determine binding regions
Cross-reactivity testing against related plant cyclins
Evaluation in knockout/knockdown plant materials
Application-Specific Considerations:
For Western blot: Evaluate background levels and signal-to-noise ratio
For immunoprecipitation: Compare efficiency of target protein recovery
For ChIP: Assess enrichment of known target sequences
For ELISA: Compare detection limits and dynamic range
When selecting a CYCT1-1 antibody, researchers should consider running validation experiments with their specific plant species and experimental conditions to determine which preparation offers optimal performance for their research needs .
CYCT1-1 antibody is increasingly being utilized in cutting-edge research on plant stress responses:
Stress-Induced Expression Profiling:
Subject plants to various stresses (drought, salinity, pathogens, heat)
Use CYCT1-1 antibody for Western blot analysis at different time points
Correlate CYCT1-1 protein levels with transcriptional activity changes
Identify stress conditions that specifically modulate CYCT1-1 expression or localization
Chromatin Dynamics During Stress:
Perform ChIP-seq with CYCT1-1 antibody under normal and stress conditions
Map genome-wide redistribution of CYCT1-1 during stress response
Integrate with transcriptome data to correlate CYCT1-1 binding with gene expression changes
Identify stress-specific transcriptional programs regulated by CYCT1-1
Post-Translational Modification Analysis:
Use CYCT1-1 antibody for immunoprecipitation from stressed plant tissues
Analyze precipitated proteins by mass spectrometry to identify stress-induced modifications
Generate phospho-specific antibodies if key regulatory sites are identified
Map kinase pathways that regulate CYCT1-1 during stress responses
Protein Complex Remodeling:
Compare CYCT1-1 interaction partners under normal and stress conditions
Identify stress-specific protein-protein interactions
Determine if stress alters CYCT1-1 association with the transcriptional machinery
Investigate if CYCT1-1 recruits specific stress-response transcription factors
These emerging applications highlight the importance of CYCT1-1 antibody as a tool for understanding plant adaptation mechanisms to environmental challenges.
When applying CYCT1-1 antibody across different plant species, researchers should address several important considerations:
Epitope Conservation Assessment:
Perform sequence alignment of CYCT1-1 across target species
Identify the epitope recognized by the antibody (contact supplier for this information)
Evaluate conservation of this epitope region in target species
Predict potential cross-reactivity based on sequence homology
Validation in Each Species:
Begin with Western blot analysis to confirm detection and determine apparent molecular weight
Verify specificity using genetic controls when available (knockouts, RNAi lines)
Determine optimal working conditions, which may vary between species
Consider using multiple antibodies targeting different epitopes for confirmation
Optimization Guidelines by Application:
| Application | Species-Specific Considerations | Optimization Approach |
|---|---|---|
| Western Blot | Protein extraction buffer composition | Test different extraction methods optimized for each species |
| Immunoprecipitation | Binding conditions and stringency | Adjust salt and detergent concentrations based on species |
| Immunohistochemistry | Fixation and tissue preparation | Optimize fixation time and antigen retrieval for each species |
| ChIP | Crosslinking efficiency | Adjust crosslinking time based on tissue type and species |
Evolutionary Interpretation:
Use phylogenetic analysis to contextualize differences in antibody reactivity
Consider evolutionary distance when interpreting cross-reactivity patterns
Leverage cross-species comparisons to identify conserved functional domains
Document species-specific variations that may reflect adaptive evolution
Carefully validated cross-species applications of CYCT1-1 antibody can provide valuable comparative insights into cyclin T1 function across plant lineages .